Advertisement
Screener

MARKER THERAPEUTICS, INC. (MRKR) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

MARKER THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where MARKER THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $12.01M went out.
  • Fiscal year ended 2025-12-31: from financing, $9.86M came in.
  • Fiscal year ended 2025-12-31: change in cash, $2.15M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldOtherNot split outChange in cash
2025-12-31-$12.01M$9.86M-$2.15M
2024-12-31-$10.91M$14.93M$4.08M
2023-12-31-$16.44M$18.66M$1.01M$3.33M
2022-12-31-$26.97M-$4.95M$202.13K$11.80M
2021-12-31-$27.28M-$3.13M$52.55M$43.50M
2020-12-31-$20.03M-$9.25M$6.19M$550.00K*-$22.55M
2019-12-31-$18.28M-$374.98K$0.00$816.48K*-$17.84M
2018-12-31-$14.48M-$147.67K-$71.71K$18.13K$71.30M*$56.62M
2017-12-31-$8.44M$0.00-$310.49K$0.00$6.03M*
2016-12-31-$6.51M$0.00$18.13K$7.77M*
2015-12-31-$4.34M$2.33M$8.45M*
2014-12-31-$2.19M$1.88M
2013-12-31-$694.58K$709.33K*
2012-12-31-$1.59M$555.00K$817.19K*
2011-12-31-$1.31M$683.45K$140.00K$713.13K*
2010-12-31-$925.04K$807.13K*

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldOtherNot split outChange in cash
2026-06-30-$3.72M*
2026-03-31-$1.40M-$1.40M
2025-12-31-$1.90M*$0.00*
2025-09-30-$2.74M*$9.86M*
2025-06-30-$1.88M*
2025-03-31-$5.50M-$5.50M
2024-12-31-$4.70M*$14.89M*
2024-09-30$1.20M*$0.00*
2024-06-30-$3.57M*$7.70K*
2024-03-31-$3.84M$49.10K-$3.79M
2023-12-31-$2.37M*$0.00*$5.13K*
2023-09-30-$1.13M*$0.00*$394.67K*
2023-06-30-$7.06M*$18.78M*$0.00*
2023-03-31-$5.89M-$112.61K$619.97K-$5.38M
2022-12-31-$6.31M*-$127.34K*$138.56K*
2022-09-30-$7.65M*-$99.37K*$0.00*
2022-06-30-$794.71K*-$2.27M*$63.57K*
2022-03-31-$12.23M-$2.45M$0.00$28.80M
2021-12-31-$4.86M*-$349.84K*$0.00*
2021-09-30-$7.54M*-$980.27K*$0.00*
2021-06-30-$6.79M*-$399.77K*-$103.83K*
2021-03-31-$8.10M-$1.40M$52.66M$43.16M
2020-12-31-$5.50M*-$4.10M*$4.00M*
2020-09-30-$6.13M*-$1.22M*$2.19M*
2020-06-30-$4.30M*-$3.83M*$0.00*
2020-03-31-$4.10M-$99.82K$0.00$550.00K*-$3.65M
2019-12-31-$4.56M*-$12.86K*$0.00*
2019-09-30-$5.66M*-$56.74K*$0.00*$753.35K*
2019-06-30-$4.18M*-$82.26K*$0.00*
2019-03-31-$3.88M-$223.13K$57.74K-$4.04M
2018-12-31-$6.16M*-$147.67K*-$71.71K*$0.00*$63.83M*
2018-09-30-$3.57M*$0.00*$0.00*
2018-06-30-$2.40M*$0.00*$0.00*$7.38M*
2018-03-31-$2.35M$0.00$18.13K
2017-12-31-$2.48M*$0.00*$0.00*
2017-09-30-$2.03M*$0.00*
2017-06-30-$2.01M*$0.00*$6.05M*
2017-03-31-$1.92M$0.00
2016-12-31-$1.75M*$0.00*
2016-09-30-$1.97M*$7.79M*
2016-06-30-$1.95M*
2016-03-31-$829.76K
2015-12-31-$850.97K*$1.34M*
2015-09-30-$1.66M*$4.65M*
2015-06-30-$813.18K*$0.00*$2.46M*
2015-03-31-$1.01M$2.33M
2014-12-31-$669.20K*-$220.00K*
2014-09-30-$906.50K*$1.51M*
2014-06-30-$238.49K*$583.00K*
2014-03-31-$372.95K$0.00
2013-12-31$59.97K*
2013-09-30-$134.95K*-$4.30K*
2013-06-30-$165.16K*$0.00*
2013-03-31-$454.45K$235.95K
2012-12-31$100.00K*
2012-09-30-$272.29K*$0.00*
2012-06-30-$491.32K*$370.00K*
2012-03-31-$332.38K$85.00K
2011-12-31-$433.14K*$488.70K*$60.79K*
2011-09-30-$141.61K*$110.00K*$79.21K*
2011-06-30-$330.70K*
2011-03-31-$404.42K
2010-12-31-$33.34K*
2010-09-30-$254.82K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Rocket One Inc. (RKTO)United States$0.019B
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Lipocine Inc. (LPCN)United States$0.017B-1.79
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66